Corentec
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Corentec makes artificial joints, replacement hip and knee implants used in orthopaedic surgery, and is listed on KOSDAQ, South Korea's tech and small-cap exchange.
Its products are supplied to hospitals and surgical facilities, including through a dedicated US subsidiary, Corentec America. The company describes itself as the first domestic Korean manufacturer specialised in artificial joints and holds proprietary surface-treatment and design technologies; it was also the first in the world to apply three-dimensional printing technology to artificial-joint production.
Summary is AI-generated and may contain errors · figures from DART filings
Corentec consolidates two main subsidiaries, Corentec America for US distribution and Sunhealthcare International, which operates health-screening services and a US orthopaedic surgery hospital, under its group structure.
Corentec in five facts
What does Corentec do?
Corentec makes artificial joints, replacement hip and knee implants used in orthopaedic surgery, and is listed on KOSDAQ, South Korea's tech and small-cap exchange.
Where is Corentec listed and in which sector?
Corentec (Korean name: 코렌텍) trades under KRX code 104540 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Corentec?
Its market capitalisation was US$51.1M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Corentec's latest annual revenue and operating profit?
For fiscal year 2025, Corentec reported revenue of US$75.8M, operating profit of US$6.9M and net income of US$5.3M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 7.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Operating results (consolidated) (preliminary) (fair disclosure)
Corentec filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$17.5M (+10.1% year on year), operating profit of US$987K (+6.3% year on year) and net income of US$759K (from a loss a year earlier).
Earnings · Jul 24 - Operating results (consolidated) (preliminary) (fair disclosure)
Corentec filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$16.9M (+8.6% year on year), operating profit of US$609K (−15.1% year on year) and net income of US$915K (−50.8% year on year).
Earnings · May 8 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Corentec reported consolidated results for FY2025: revenue of US$69M (+7.2% year on year), operating profit of US$6.2M (+131.8% year on year) and net income of US$3.81M (from a loss a year earlier).
Earnings · Feb 11 - Operating results (consolidated) (preliminary) (fair disclosure)
Corentec filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$19.6M (+8.9% year on year), operating profit of US$2.05M (+39.7% year on year) and net income of US$1.68M (+137.3% year on year).
Earnings · Feb 10